Online:
Visits:
Stories:
Profile image
By marketresearchnest
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Chronic Obstructive Pulmonary Disease Therapeutics Pipeline Market H1 2017

Friday, May 19, 2017 6:20
% of readers think this story is Fact. Add your two cents.

(Before It's News)

MarketResearchNest.com adds “Chronic Obstructive Pulmonary Disease – Pipeline Review, H1 2017” new report to its research database. The report spread across in multiple pages with table and figures in it.

 

Latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease – Pipeline Review, H1 2017, provides an overview of the Chronic Obstructive Pulmonary Disease (Respiratory) pipeline landscape.

Chronic obstructive pulmonary disease (COPD) is a group of lung diseases. It is characterized by inability to completely breathe out air from the lungs leading to shortness of breath. The airflow to the lungs is further blocked. Other symptoms include cough, fatigue and chest pain. The disease tends to worsen over the time hence increasing the complications. The risk factors involved in causing COPD include smoking as the primary reason. Exposure to chemicals and air pollution also contribute in the development of COPD.

Browse full table of contents and data tables at https://www.marketresearchnest.com/chronic-obstructive-pulmonary-disease-pipeline-review-h1-2017.html

The Chronic Obstructive Pulmonary Disease (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Chronic Obstructive Pulmonary Disease (COPD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 5, 1, 14, 38, 23, 85, 25 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 9 and 1 molecules, respectively.

Chronic Obstructive Pulmonary Disease (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

 

Chronic Obstructive Pulmonary Disease – Companies Involved in Therapeutics Development

Abeona Therapeutics Inc

Achillion Pharmaceuticals Inc

Adamis Pharmaceuticals Corp

Advanced Inhalation Therapies (AIT) Ltd

Advinus Therapeutics Ltd

AlgiPharma AS

Allinky Biopharma

Alteogen Inc

Amakem NV

Angiocrine Bioscience Inc

Angion Biomedica Corp

apceth Biopharma GmbH

Apellis Pharmaceuticals Inc

Aridis Pharmaceuticals LLC

Astellas Pharma Inc

AstraZeneca Plc

Asubio Pharma Co Ltd

Axikin Pharmaceuticals Inc

Bayer AG

Beech Tree Labs Inc

Bioneer Corp

Boehringer Ingelheim GmbH

C4X Discovery Holdings PLC

Carolus Therapeutics Inc

Cellular Biomedicine Group Inc

Celon Pharma SA

Chiesi Farmaceutici SpA

Circassia Pharmaceuticals Plc

CSL Ltd

Cytokinetics Inc

Daiichi Sankyo Company Ltd

Diffusion Pharmaceuticals Inc

Domainex Ltd

Enterprise Therapeutics Ltd

Errant Gene Therapeutics LLC

F. Hoffmann-La Roche Ltd

Foresee Pharmaceuticals LLC

Galapagos NV

Gilead Sciences Inc

GlaxoSmithKline Plc

Glenmark Pharmaceuticals Ltd

Grifols SA

Hanmi Pharmaceuticals Co Ltd

iCeutica Inc

InMed Pharmaceuticals Inc

Innate Pharma SA

Insmed Inc

Intech Biopharm Ltd

Invion Ltd

Jiangsu Hansoh Pharmaceutical Group Co Ltd

Johnson & Johnson

KaloBios Pharmaceuticals Inc

Kissei Pharmaceutical Co Ltd

Kyowa Hakko Kirin Co Ltd

Medestea Research & Production SpA

MedImmune LLC

Mereo Biopharma Group Plc

Meridigen Biotech Co Ltd

Microbion Corp

Novartis AG

Odan Laboratories Ltd

OPKO Health Inc

Orchid Pharma Ltd

Orion Oyj

Pfizer Inc

Pharmaxis Ltd

Promedior Inc

ProMetic Life Sciences Inc

Proteostasis Therapeutics Inc

Pulmagen Therapeutics LLP

Pulmatrix Inc

Qu Biologics Inc

Quark Pharmaceuticals Inc

Re-Pharm Ltd

Regeneron Pharmaceuticals Inc

Respira Therapeutics Inc

Respiratorius AB

rEVO Biologics Inc

Rhizen Pharmaceuticals SA

SATT North SAS

Seoul Pharma Co Ltd

sterna biologicals Gmbh & Co KG

Sun Pharma Advanced Research Company Ltd

Sunovion Pharmaceuticals Inc

Synedgen Inc

Syntrix Biosystems Inc

Takeda Pharmaceutical Company Ltd

Teva Pharmaceutical Industries Ltd

Therabron Therapeutics Inc

Theravance Biopharma Inc

Torrent Pharmaceuticals Ltd

Unizyme Laboratories A/S

Vectura Group Plc

Verona Pharma Plc

Vertex Pharmaceuticals Inc

Yuhan Corp

Yungjin Pharm Co Ltd

 

Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=205652

 

Scope of this Report

- The pipeline guide provides a snapshot of the global therapeutic landscape of Chronic Obstructive Pulmonary Disease (Respiratory).
- The pipeline guide reviews pipeline therapeutics for Chronic Obstructive Pulmonary Disease (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Chronic Obstructive Pulmonary Disease (Respiratory) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Chronic Obstructive Pulmonary Disease (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Chronic Obstructive Pulmonary Disease (Respiratory)

 

Request Sample Copy at https://www.marketresearchnest.com/requestsample.php?reportid=205652

 

About Us:                         

MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.

 

Contact Us

Mr. Jeet Jain

Sales Manager

sales@marketresearchnest.com

+1-240-284-8070

Connect with us:  Google+ | LinkedIn | Twitter | Facebook

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.